Clinical trial / 2014
Pumpkin seed oil improved symptoms in benign prostatic hyperplasia but less than prazosin
In a 6-month clinical trial, 100 men with benign prostatic hyperplasia were randomly assigned to receive prostafit or prazosin. Both groups improved in International Prostatic Symptom Score from baseline to 6 months, especially in group 2 with scores of 18 versus 22 (36% versus 44%), while quality of life was better in group 2 (25.5 vs 31.5; 51% vs 63%). Prostate specific antigen levels did not change significantly, and no complications occurred.
- Study type
- Randomized controlled trial
- Who was studied
- 100 men with benign prostatic hyperplasia, Iran
- What was measured
- Prostate symptoms, quality of life, and prostate specific antigen
THE PAPER
Pumpkin seed oil (prostafit) or prazosin? Which one is better in the treatment of symptomatic benign prostatic hyperplasia.
Shirvan MK, Mahboob MR, Masuminia M, Mohammadi S. J Pak Med Assoc, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.